21-44288459-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_ModeratePP5
The NM_000383.4(AIRE):c.652+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000226 in 1,592,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000383.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AIRE | NM_000383.4 | c.652+1G>T | splice_donor_variant, intron_variant | ENST00000291582.6 | NP_000374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AIRE | ENST00000291582.6 | c.652+1G>T | splice_donor_variant, intron_variant | 1 | NM_000383.4 | ENSP00000291582.5 | ||||
AIRE | ENST00000530812.5 | n.1205G>T | non_coding_transcript_exon_variant | 4/12 | 2 | |||||
AIRE | ENST00000527919.5 | n.1196+1G>T | splice_donor_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000964 AC: 24AN: 248874Hom.: 0 AF XY: 0.0000889 AC XY: 12AN XY: 134982
GnomAD4 exome AF: 0.0000181 AC: 26AN: 1439672Hom.: 0 Cov.: 30 AF XY: 0.0000153 AC XY: 11AN XY: 717230
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152372Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74512
ClinVar
Submissions by phenotype
Polyglandular autoimmune syndrome, type 1 Pathogenic:5
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 13, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Apr 22, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 07, 2024 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | This sequence change affects a donor splice site in intron 5 of the AIRE gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in AIRE are known to be pathogenic (PMID: 11524731, 26141571). This variant is present in population databases (rs199612115, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. ClinVar contains an entry for this variant (Variation ID: 370839). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
AIRE-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2024 | The AIRE c.652+1G>T variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant was reported in three unaffected individuals who were part of a carrier study of autosomal recessive inherited disorders (Chau et al. 2022. PubMed ID: 35314707). This variant was reported in an individual with Autoimmune polyendocrinopathy with candidiasis and ectodermal dysplasia (Chau et al 2022. PubMed ID: 35314707; Heino M et al 2001. PubMed ID: 11524731; Placeholder for https://www.ncbi.nlm.nih.gov/pmc/?term=4544753 ; Kisand K et al 2015. PubMed ID: 26141571; Baralle D et al 2005. PubMed ID: 16199547). This variant is reported in 0.13% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-45708342-G-T). Variants that disrupt the consensus splice donor site in AIRE are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 15, 2023 | Identified as a single heterozygous variant in patients in published literature, but additional evidence is not available (PMID: 35314707); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 35314707) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at